These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Repurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularization. McAnally D; Siddiquee K; Gomaa A; Szabo A; Vasile S; Maloney PR; Divlianska DB; Peddibhotla S; Morfa CJ; Hershberger P; Falter R; Williamson R; Terry DB; Farjo R; Pinkerton AB; Qi X; Quigley J; Boulton ME; Grant MB; Smith LH PLoS One; 2018; 13(9):e0202436. PubMed ID: 30208056 [TBL] [Abstract][Full Text] [Related]
4. Prophylaxis for the international traveller. Macpherson DW Can Fam Physician; 1985 Nov; 31():2083-7. PubMed ID: 21274123 [TBL] [Abstract][Full Text] [Related]
5. Chloroquine dose for malaria prevention. Dresser CK Can Fam Physician; 1986 Feb; 32():231. PubMed ID: 21267237 [No Abstract] [Full Text] [Related]
6. Adverse effects of antimalarials. An update. Luzzi GA; Peto TE Drug Saf; 1993 Apr; 8(4):295-311. PubMed ID: 8481216 [TBL] [Abstract][Full Text] [Related]
7. Antimalarial drugs. An update. Warhurst DC Drugs; 1987 Jan; 33(1):50-65. PubMed ID: 3545765 [TBL] [Abstract][Full Text] [Related]
8. Relapsing malaria infection acquired in Kenya. Patterson JE; Bia FJ; Miller K; McPhedran P Yale J Biol Med; 1987; 60(3):245-53. PubMed ID: 3300055 [TBL] [Abstract][Full Text] [Related]
9. Malaria chemoprophylaxis in travellers to east Africa: a comparative prospective study of chloroquine plus proguanil with chloroquine plus sulfadoxine-pyrimethamine. Fogh S; Schapira A; Bygbjerg IC; Jepsen S; Mordhorst CH; Kuijlen K; Ravn P; Rønn A; Gøtzsche PC Br Med J (Clin Res Ed); 1988 Mar; 296(6625):820-2. PubMed ID: 3130927 [TBL] [Abstract][Full Text] [Related]
10. Risk of acute non-specific upper respiratory tract infections in healthy men taking dapsone-pyrimethamine for prophylaxis against malaria. Lee PS; Lau EY Br Med J (Clin Res Ed); 1988 Mar; 296(6626):893-5. PubMed ID: 3129063 [TBL] [Abstract][Full Text] [Related]
11. A quantitative approach to recommendations on malaria prophylaxis. Pappaioanou M; Lobel HO; Campbell CC Bull World Health Organ; 1988; 66(4):477-84. PubMed ID: 3048761 [TBL] [Abstract][Full Text] [Related]
12. Malaria prophylaxis with proguanil and sulfisoxazole in children living in a malaria endemic area. Pang LW; Limsomwong N; Singharaj P; Canfield CJ Bull World Health Organ; 1989; 67(1):51-8. PubMed ID: 2706727 [TBL] [Abstract][Full Text] [Related]
13. Toxicity of antimalarial drugs. Peto TE J R Soc Med; 1989; 82 Suppl 17(Suppl 17):30-3; discussion 33-4. PubMed ID: 2693722 [No Abstract] [Full Text] [Related]
15. Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1985 Apr; 34(14):185-90, 195. PubMed ID: 3156271 [No Abstract] [Full Text] [Related]
16. Leads from the MMWR. Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum. JAMA; 1985 May; 253(17):2483-6. PubMed ID: 3157011 [No Abstract] [Full Text] [Related]
17. Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1986 Jan; 35(2):21-22, 27. PubMed ID: 3001495 [No Abstract] [Full Text] [Related]
18. Malaria prophylaxis in travelers. Wolff JA; Smith RP J Fam Pract; 1980 Nov; 11(6):879-82. PubMed ID: 7005388 [TBL] [Abstract][Full Text] [Related]
19. Practical therapeutics malaria chemoprophylaxis. Juma FD East Afr Med J; 1984 Mar; 61(3):254-9. PubMed ID: 6383777 [No Abstract] [Full Text] [Related]